Top compounds associated with response to SLC37A1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.07 0.07
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.057 0.07
mRNA PI-103 CTRPv2 pan-cancer AAC -0.067 0.07
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.067 0.07
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.059 0.07
mRNA parbendazole CTRPv2 pan-cancer AAC -0.058 0.08
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.072 0.08
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.08
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.08
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.058 0.08
Download CSV